Pure Erythroid Leukemia Presenting in a HIV-Positive Patient Matthew J. Oberley, David T. Yang Clinical Lymphoma, Myeloma and Leukemia Volume 14, Issue 1, Pages e35-e38 (February 2014) DOI: 10.1016/j.clml.2013.09.017 Copyright © 2014 Elsevier Inc. Terms and Conditions
Figure 1 (A) Peripheral Blood Smear With Circulating Blasts (×100, Wright Stain). (B) Bone Marrow Aspirate Showing Blast Population (×100, Giemsa-Wright Stain). (C) Bone Marrow Aspirate Showing Periodic Acid–Schiff-Positive Cytoplasmic Vacuoles in the Blast Population (×100, Periodic Acid–Schiff). (D) Bone Marrow Core Biopsy (×40, Hematoxylin and Eosin). (E) Bone Marrow Core Biopsy (×100, Hemoglobin A Immunohistochemical Evaluation). (F) Bone Marrow Core Biopsy, E-Cadherin Immunohistochemical Evaluation (×100) Clinical Lymphoma, Myeloma and Leukemia 2014 14, e35-e38DOI: (10.1016/j.clml.2013.09.017) Copyright © 2014 Elsevier Inc. Terms and Conditions
Figure 2 (A, B) Flow Cytometry Scatter Plots of Bone Marrow Aspirate. The CD45dim Blasts are Highlighted in red, Whereas Lymphocytes are Highlighted in Green. The Blast Population is CD34+, CD71+ and MPO–. The Full Immunophenotype is Described in the Text Clinical Lymphoma, Myeloma and Leukemia 2014 14, e35-e38DOI: (10.1016/j.clml.2013.09.017) Copyright © 2014 Elsevier Inc. Terms and Conditions